Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals
(AUPH)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Lupkynis
Voclosporin
2021-01-22
2023-2037
Lupus nephritis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Voclosporin
drug interactions
,
eye diseases
,
kidney diseases
,
focal segmental glomerulosclerosis
,
covid-19
,
lupus nephritis
,
nephritis
,
psoriasis
,
keratoconjunctivitis sicca
,
dry eye syndromes
,
kidney transplantation
,
keratoconjunctivitis
,
syndrome
,
chronic disease
Mycophenolate sodium
immunosuppression therapy
,
healthy volunteers/patients
,
microscopic polyangiitis
,
congenital abnormalities
,
chronic kidney failure
,
systemic scleroderma
,
myelodysplastic syndromes
,
preleukemia
,
syndrome
,
hypoglycemia
,
lung diseases
,
interstitial lung diseases
,
localized scleroderma
,
diffuse scleroderma
,
hypertension
,
iga glomerulonephritis
,
renal hypertension
,
diabetes mellitus
,
bullous pemphigoid
,
psoriasis
,
lupus nephritis
,
nephritis
,
systemic lupus erythematosus
,
type 1 diabetes mellitus
,
neuromyelitis optica
,
pemphigus
,
myasthenia gravis
,
diabetic nephropathies
,
multiple sclerosis
,
cardiovascular diseases
,
lung transplantation
,
sarcoidosis
,
pulmonary sarcoidosis
,
membranous glomerulonephritis
,
kidney transplantation
,
liver transplantation
,
heart transplantation
,
kidney diseases
,
renal insufficiency
,
polyomavirus infections
,
corneal transplantation
,
liver diseases
,
hiv infections
,
graft vs host disease
,
hematopoietic stem cell transplantation
Bevifimod
carcinoma
,
neoplasms
,
type 2 diabetes mellitus
,
non-small-cell lung carcinoma
,
sarcoidosis
,
hidradenitis suppurativa
,
abscess
,
fistula
,
asthma
,
non-hodgkin lymphoma
,
multiple myeloma
,
lymphoma
,
hodgkin disease
,
mantle-cell lymphoma
,
skin diseases
,
arthritis
,
ankylosing spondylitis
,
prostatic neoplasms
,
ulcerative colitis
,
juvenile arthritis
,
infections
,
psoriatic arthritis
,
chronic renal insufficiency
,
kidney diseases
,
inflammation
,
protein-energy malnutrition
,
congenital heart defects
,
premature birth
,
bronchopulmonary dysplasia
,
respiratory syncytial virus infections
,
inflammatory bowel diseases
,
precocious puberty
,
exocrine pancreatic insufficiency
,
mucositis
,
giant cell arteritis
,
spondylarthritis
,
hypoalbuminemia
,
oxidative stress
,
interstitial cystitis
,
rheumatoid arthritis
,
psoriasis
,
crohn disease
,
malnutrition
,
diabetes mellitus
,
hip fractures
,
coronary artery disease
,
cardiovascular diseases
,
esophageal neoplasms
,
bone fractures
,
hiv infections
,
acquired immunodeficiency syndrome
,
covid-19
,
human influenza
,
pressure ulcer
,
malaria
,
pain
,
fatigue
,
stomach neoplasms
,
gastrointestinal stromal tumors
,
chronic pain
,
failed back surgery syndrome
,
sciatica
,
critical illness
,
enteral nutrition
,
bradycardia
,
hepatocellular carcinoma
,
liver neoplasms
,
influenza b virus
Nepidermin
bile duct neoplasms
,
cholangiocarcinoma
,
klatskin tumor
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use